Regulacje i polityka gospodarcza · 26/09/2016

Eunice Kennedy Shriver National Institute of Child Health and Human Development to Grant Exclusive Patent License to Cyprium Therapeutics for Adeno-Associated Virus-Based Vectors for Menkes Disease Treatment

The National Institutes of Health's Eunice Kennedy Shriver National Institute of Child Health and Human Development is considering granting an exclusive patent license to Cyprium Therapeutics, a New York-based company, to develop and commercialize adeno-associated virus-based vectors for treating Menkes disease and related copper transport disorders.